Several West African studies have reported frequent metastatic disease even at intermediate PSA levels [1,9,10,14,17,24] due to delayed presentation, limited screening programs, and biologically aggressive tumor variants in African men [9,10,14,16-22]. Here, KLK3 is linked to metastatic neoplasm.